s.poulsen
TL3 Regular · Ljubljana, SI
Clinician. Posts general information only, and says so every time.
Joined 26 August 2024 · last posted 2d · groups: clinicians
134 posts, newest first. Showing up to 150.
-
About the Adverse events category Replied, post #7 · Safety › Adverse events · 26 Jul 2026 · 28 likes I had written a reply contradicting post #3 and deleted it. Here is what survived. Reporting an adverse event to the national reporting scheme is possible for anybody…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #63 · Practice › Interactions · 24 Jul 2026 · 0 likes The practical advice most consistently given by pharmacists here is to keep the timing of other oral medication consistent rather than to change it, because consistency…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #83 · Practice › Dosing & titration · 21 Jul 2026 · 1 like If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #82 · Nutrition & Training › Protein & intake · 19 Jul 2026 · 25 likes Two things can be true about Protein density versus volume at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #96 · Analytics › Home & field testing · 17 Jul 2026 · 10 likes A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #7 · Practice › Interactions · 8 Jul 2026 · 23 likes Oral medications with a narrow therapeutic index are the ones where that matters most. The interaction is about rate and timing rather than about the total absorbed, in…
-
Prescription requirements and telehealth models — a second dataset Replied, post #93 · Sourcing › Regulatory · 6 Jul 2026 · 14 likes Summarising the Prescription requirements and telehealth models thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has…
-
Naming conventions for research peptides and the confusion they cause Replied, post #23 · Compounds › Other compounds · 30 Jun 2026 · 1 like Adding the measurement that post #22 says would settle it. Peptides with cyclic or disulphide-constrained structures behave differently on a column and differently in…
-
Documenting a supplier's response to a discrepancy Replied, post #22 · Sourcing › Vendor reports · 24 Jun 2026 · 8 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. Speaking for myself and…
-
Historical amylin analogues and what happened to them Replied, post #23 · Compounds › Cagrilintide & amylin analogues · 24 Jun 2026 · 1 like Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at least one place. That overlap is part of why the combination's…
-
GLP-1 receptor distribution: central and peripheral Replied, post #74 · Pharmacology › Receptor biology · 21 Jun 2026 · 1 like GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
Packaging that arrived damaged: documenting it properly Replied, post #27 · Sourcing › Logistics · 18 Jun 2026 · 9 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Prescription portability between countries Replied, post #68 · Access › International · 18 Jun 2026 · 0 likes Post #67 answers the question as asked. The question underneath it is different. Licensed prescribing: where a compound is approved, prescribing is restricted to…
-
What to include when your question involves a chromatogram — one year on Replied, post #40 · Start Here › How to Ask · 17 Jun 2026 · 0 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #40 · Start Here › Welcome · 14 Jun 2026 · 0 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #31 · Pharmacology › Formulation chemistry · 13 Jun 2026 · 0 likes I had written a reply contradicting post #29 and deleted it. Here is what survived. I would put moderate confidence on the mainstream reading of Solubility limits and…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #53 · Compounds › Semaglutide · 6 Jun 2026 · 20 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #78 · Sourcing › Red flags · 6 Jun 2026 · 32 likes That is consistent with mine, for whatever one more account is worth.
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #38 · Analytics › Home & field testing · 4 Jun 2026 · 23 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Reading a trial's population section before its results Replied, post #45 · Evidence › Trials · 23 May 2026 · 21 likes Post #42 is right about the mechanism and I think understates the practical bit. Absolute and relative effects answer different questions. Write down the event rate in…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #35 · Clinical › Bloodwork · 22 May 2026 · 29 likes If someone has run Liver enzymes drifting properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Why the timeline is on the right and not the left — what changed since Replied, post #37 · Meta › Site feedback · 16 May 2026 · 22 likes What I would want before treating timeline as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #25 · Analytics › HPLC & UHPLC · 11 May 2026 · 0 likes Typical suitability criteria are a replicate area relative standard deviation below about two per cent, a tailing factor inside a defined window, a resolution minimum…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #29 · Compounds › Tirzepatide · 7 May 2026 · 0 likes The documentation on Tirzepatide and nausea is better than this thread and I say that as someone who has posted in the thread.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #34 · Practice › Reconstitution · 4 May 2026 · 1 like If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is a lower concentration rather than a more careful hand. The interesting part…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #20 · Compounds › Repair & healing peptides · 3 May 2026 · 17 likes This follows post #17 rather than contradicting it. What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #12 · Practice › Storage & stability · 1 May 2026 · 22 likes Building on post #9 rather than restating it. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption…
-
Request: show the solution author in the topic list — what changed since Replied, post #7 · Meta › Feature requests · 30 Apr 2026 · 0 likes I had written a reply contradicting post #3 and deleted it. Here is what survived. Counter-request, gently: please do not add anything on hover. It does not exist on a…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #9 · Compounds › Tirzepatide · 29 Apr 2026 · 2 likes The arithmetic on Tirzepatide and nausea is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #4 · Compounds › Semaglutide · 22 Apr 2026 · 12 likes Narrowing post #3, because the general version has more than one answer. The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #38 · Evidence › Journal club · 14 Apr 2026 · 12 likes I had written a reply contradicting post #34 and deleted it. Here is what survived. My experience of orforglipron phase 2 contradicts the reply above. I am posting it…
-
A fridge failure and how I assessed the contents afterwards Replied, post #7 · Devices › Cold chain · 13 Apr 2026 · 3 likes Everything in post #5 holds. The case it does not cover is the one I have. Dry ice is rarely used for this material and brings its own transport constraints. Its…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #24 · Practice › Interactions · 11 Apr 2026 · 5 likes Post #22 is right about the mechanism and I think understates the practical bit. Two questions I would want answered before drawing anything from the widely repeated…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #51 · Practice › Reconstitution · 22 Mar 2026 · 5 likes Thank you for taking the time. That was more work than a reply usually is.
-
Grapefruit: why this class is not the class that cares Replied, post #58 · Practice › Interactions · 20 Mar 2026 · 3 likes Delayed gastric emptying is the mechanism behind most of the plausible interactions in this class: anything whose absorption depends on how quickly the stomach empties…
-
CJC-1295 with and without DAC: what the modification does Replied, post #11 · Compounds › Secretagogues & GH axis · 11 Mar 2026 · 1 like Post #7 and I disagree about the size of the effect, not about the direction. CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin…
-
Guidelines revision: what changed and why — one year on Replied, post #80 · Meta › Announcements · 9 Mar 2026 · 23 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #20 · Analytics › COA interpretation · 26 Feb 2026 · 3 likes Worth separating two things that post #18 runs together. A request rather than an answer: could whoever has the primary source for Reused chromatograms across lots post…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #127 · Practice › Dosing & titration · 21 Feb 2026 · 27 likes The starting dose in most of these programmes is a tolerance step and produces little effect by design. Judging the compound at the starting dose is judging the wrong…
-
Dead volume across syringe and needle combinations Replied, post #75 · Devices › Syringes & needles · 20 Feb 2026 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #93 · Wellbeing › Mental health · 18 Feb 2026 · 15 likes Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and anxiety. Addressing sleep separately from mood matters.…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #48 · Analytics › Method validation · 13 Feb 2026 · 21 likes I read post #44 twice before replying, because I had assumed the opposite. Precision has two levels worth distinguishing: repeatability within a run and intermediate…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #41 · Start Here › Welcome · 11 Feb 2026 · 28 likes Do not feel obliged to reply to every reply on your own topic. A single "that answered it" and a marked solution is the most useful thing you can do for the next person…
-
Trifluoroacetate content and its consequences Replied, post #91 · Analytics › Impurities & related substances · 6 Feb 2026 · 20 likes Post #90 answers the question as asked. The question underneath it is different. Trifluoroacetate is a counter-ion rather than an impurity, and it appears in the mass…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #70 · Access › Pricing · 24 Jan 2026 · 2 likes Since Price changes keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #7 · Practice › Side effects · 31 Dec 2025 · 2 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Reading an interaction checker output critically Replied, post #67 · Practice › Interactions · 15 Dec 2025 · 0 likes Building on post #64 rather than restating it. A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database,…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #23 · Compounds › Retatrutide · 12 Dec 2025 · 13 likes This settles it for me, at least until somebody posts a reason it should not.
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #103 · Sourcing › Vendor reports · 3 Dec 2025 · 9 likes I read post #99 twice before replying, because I had assumed the opposite. Where I would push back on the vendor documentation pages consensus is the confidence, not…
-
Reading an interaction checker output critically Replied, post #56 · Practice › Interactions · 2 Dec 2025 · 0 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #2 · Practice › Administration · 30 Nov 2025 · 3 likes Picking up the opening post: that is the part I would want checked first. Subcutaneous injection into abdominal tissue, thigh or upper arm is what the licensed…
-
Airline travel with a temperature-sensitive injectable Replied, post #18 · Devices › Cold chain · 28 Nov 2025 · 1 like That is the distinction I keep failing to hold on to. Written down now.
-
Tracking that stops updating and then resumes Replied, post #48 · Sourcing › Logistics · 21 Nov 2025 · 24 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. Somebody will have a better source…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #34 · Start Here › How to Ask · 20 Nov 2025 · 28 likes Post #32 put the caveat in the right place and I want to underline it. The specific question in the title is more useful than you might think. A title like "a question…
-
Titles that describe the question, not the situation Replied, post #153 · Start Here › How to Ask · 19 Nov 2025 · 25 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
[2026 update] Splitting an overlong document into two Replied, post #47 · Documentation › Wiki requests · 4 Nov 2025 · 7 likes Where an existing document nearly covers it, extending that one is usually better than starting a new one. Two overlapping pages drift apart. It is worth checking…
-
New subcategory: rationale and scope Replied, post #109 · Meta › Announcements · 24 Oct 2025 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #4 · Start Here › Welcome · 11 Oct 2025 · 1 like Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.…
-
High-resolution MS on aggregates and what it can see Replied, post #79 · Analytics › Mass spectrometry · 28 Sep 2025 · 11 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #81 · Devices › Cold chain · 25 Sep 2025 · 18 likes I would keep Airline travel and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #43 · Pharmacology › Receptor biology · 23 Sep 2025 · 6 likes Everything in post #42 holds. The case it does not cover is the one I have. GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is…
-
Which panel is worth repeating and which is worth ignoring Replied, post #118 · Clinical › Bloodwork · 22 Sep 2025 · 13 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. Two sources, same conclusion, and I could…
-
Payment method and the leverage it gives you, ranked Replied, post #52 · Sourcing › Payments · 22 Sep 2025 · 15 likes Documentation and tax implications: payments you make for compounds might have implications for tax reporting depending on your jurisdiction. Keeping clear records…
-
Payment method and the leverage it gives you, ranked Replied, post #45 · Sourcing › Payments · 20 Sep 2025 · 32 likes Post #44 is the version of this I will quote in future. One addition. Recording the time from payment to dispatch is worth doing, because it is the part of the process…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #65 · Data & Tools › Datasets · 9 Sep 2025 · 2 likes Noted, and I have changed what I was going to do on the strength of it.
-
Second pass at: Programming during a large energy deficit Replied, post #3 · Nutrition & Training › Resistance training · 8 Sep 2025 · 7 likes Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly stable; power output might decline slightly. Expecting…
-
Gauge and length selection for subcutaneous injection Replied, post #27 · Devices › Syringes & needles · 6 Sep 2025 · 22 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Confounding by indication, explained with a concrete example Replied, post #18 · Evidence › Study critique · 2 Sep 2025 · 18 likes Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #115 · Compounds › Tirzepatide · 30 Aug 2025 · 10 likes No notes. Posting so the count is not one.
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #65 · Compounds › Retatrutide · 26 Aug 2025 · 4 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #17 · Compounds › Tirzepatide · 26 Aug 2025 · 10 likes Post #14 is right about the mechanism and I think understates the practical bit. On identity: the monoisotopic mass is close to 4813.5 Da and the electrospray series…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #31 · Practice › Storage & stability · 20 Aug 2025 · 1 like I would put moderate confidence on the mainstream reading of Freeze-thaw and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #34 · Evidence › Journal club · 14 Aug 2025 · 25 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Second pass at: LOD and LOQ: definitions people get wrong Started this topic · Analytics › Method validation · 13 Aug 2025 · 0 likes Posting this under the heading it deserves: Second pass at: LOD and LOQ: definitions people get wrong Everything below is what sits behind that. Something about LOD and…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #18 · Analytics › COA interpretation · 10 Aug 2025 · 0 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #37 · Practice › Reconstitution · 6 Aug 2025 · 13 likes A methods point on decimal-point error rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in…
-
How to research a compound with no human data without deceiving yourself Replied, post #45 · Compounds › Other compounds · 1 Aug 2025 · 0 likes On research a compound, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
An emergency department visit, described afterwards Replied, post #48 · Safety › Adverse events · 30 Jul 2025 · 24 likes On emergency department visit I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them…
-
Comparing my trajectory with the trial curves, carefully Replied, post #28 · Outcomes › Progress reports · 25 Jul 2025 · 22 likes The best progress reports here read as records rather than as arguments, and that difference is visible within a sentence.
-
Asking about a compound your prescriber has not heard of Replied, post #104 · Clinical › Prescriber conversations · 24 Jul 2025 · 0 likes Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #30 · Compounds › Cagrilintide & amylin analogues · 22 Jul 2025 · 31 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #73 · Compounds › Semaglutide · 17 Jul 2025 · 4 likes Discontinuation rates in the trials are worth reading alongside efficacy and almost never are. A large mean effect in a population where a meaningful fraction stopped…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #10 · Practice › Dosing & titration · 10 Jul 2025 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Pen wastage and its effect on real cost — the long version Replied, post #3 · Access › Pricing · 7 Jul 2025 · 6 likes Bookmarking this. I will come back when I have something worth adding.
-
Repeatability versus intermediate precision Replied, post #107 · Analytics › Method validation · 30 Jun 2025 · 8 likes Worth stating the null on repeatability versus intermediate precision before we explain it: the observation may be nothing. That possibility deserves a sentence and…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 22 Jun 2025 · 0 likes Nausea appears in the amylin-analogue literature as it does in the incretin literature, and the two are not additive in a simple way when the drugs are combined. The…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #39 · Evidence › Journal club · 15 Jun 2025 · 1 like Post #38 is right about the mechanism and I think understates the practical bit. An observation about CagriSema phase 2 combination paper that I cannot explain and am…
-
Half-life, steady state, and accumulation worked through Replied, post #57 · Pharmacology › Pharmacokinetics · 2 Jun 2025 · 1 like Washout after stopping takes roughly the same four to five half-lives as reaching steady state. A month after the last dose is not the same as none. Anyone with a…
-
Pre-registering a personal experiment, seriously Replied, post #85 · Research Methods › N-of-1 designs · 2 Jun 2025 · 23 likes Record everything that changed, not just the intervention. Personal experiments are confounded by life, and the confounders are only recoverable if they were written…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #6 · Documentation › Doc review · 27 May 2025 · 32 likes The most useful review comment names a sentence and says what is wrong with it. General approval and general concern are both hard to act on. This has been discussed…
-
Second pass at: What a reversed-phase purity number actually is Replied, post #2 · Analytics › HPLC & UHPLC · 22 May 2025 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. This is why a purity figure without the underlying chromatogram is weaker…
-
Pregnancy as an absolute contraindication Replied, post #43 · Safety › Contraindications · 18 May 2025 · 3 likes Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #90 · Sourcing › Independent verification · 13 May 2025 · 29 likes Taking post #87 at face value and following it one step further. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a…
-
Follow-up: Documentation that appears only after payment Replied, post #69 · Sourcing › Red flags · 12 May 2025 · 2 likes Narrowing post #66, because the general version has more than one answer. On Documentation I would separate what is worth knowing from what is worth acting on. The…
-
A supplier that answers analytical questions with restated claims Replied, post #71 · Sourcing › Red flags · 6 May 2025 · 32 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
Coming back to: Official shortage notices and what they authorise Started this topic · Access › Shortages · 2 May 2025 · 3 likes Official shortage notices and what they authorise Writing it up because I had to work it out twice and would rather nobody else did. Official shortage notices — I have…
-
Antibiotics and a course of something with delayed emptying Replied, post #26 · Practice › Interactions · 23 Apr 2025 · 2 likes Second-hand on antibiotics, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #77 · Compounds › Semaglutide · 14 Apr 2025 · 0 likes Post #73 put the caveat in the right place and I want to underline it. Injection site does not appear to matter much for semaglutide exposure. The published comparisons…
-
Reading a trial's population section before its results — does this still hold? Replied, post #7 · Evidence › Trials · 13 Apr 2025 · 7 likes Composite endpoints should be read component by component. A composite driven entirely by its softest component is a different finding from one where the components…
-
Checking someone else's arithmetic: a worked example thread Replied, post #37 · Practice › Reconstitution · 10 Apr 2025 · 0 likes If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is a lower concentration rather than a more careful hand. Someone should write…
-
Requesting a page: what makes a good request Replied, post #48 · Documentation › Wiki requests · 7 Apr 2025 · 30 likes Picking up post #47: that is the part I would want checked first. Correction requests: if you spot an error in a maintained page, note it here with the specific…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #62 · Compounds › Cagrilintide & amylin analogues · 30 Mar 2025 · 28 likes Adding the measurement that post #60 says would settle it. The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #28 · Practice › Reconstitution · 26 Mar 2025 · 0 likes On 10 mg vial reconstituted three, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #115 · Access › International · 22 Mar 2025 · 29 likes Customs practice varies between entry points within the same country, which is why two people in the same jurisdiction report different experiences honestly.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #59 · Practice › Reconstitution · 21 Mar 2025 · 15 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #153 · Sourcing › Vendor reports · 19 Mar 2025 · 13 likes Date the submission as well as the result. Turnaround is part of what people want to know and it disappears if only one date is recorded. I have said this before in a…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #98 · Analytics › COA interpretation · 19 Mar 2025 · 10 likes Check the lot on the vial against the lot on the document before anything else. It is the cheapest check available and it is the one that catches the mismatches that…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #9 · Access › Insurance & coverage · 9 Mar 2025 · 16 likes The most useful thing anyone has posted about Coverage in this category was a table of what had been measured and by whom. That is what I would want again.
-
Filing a first vendor report: a worked example Replied, post #3 · Sourcing › Vendor reports · 8 Mar 2025 · 17 likes The format we ask for is compound, lot, testing service, method as reported, result, and the certificate figure for the same lot. A report missing any of those goes to…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #102 · Sourcing › Regulatory · 4 Mar 2025 · 9 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #28 · Compounds › Semaglutide · 4 Mar 2025 · 1 like The question underneath SELECT is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would expect to…
-
Deamidation and the close-eluting pair it produces Replied, post #4 · Analytics › Impurities & related substances · 2 Mar 2025 · 29 likes I disagree with the framing of deamidation above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked.…
-
Second pass at: Regression to the mean in progress reports Replied, post #71 · Research Methods › Statistics · 28 Feb 2025 · 12 likes Post #68 is the version of this I will quote in future. One addition. Where the Regression reasoning breaks down for me is the step from the group result to the…
-
Protein density versus volume when you cannot eat much Replied, post #54 · Nutrition & Training › Protein & intake · 2 Feb 2025 · 0 likes Post #51 answers the question as asked. The question underneath it is different. Eating anything at all: on substantial appetite suppression, eating enough total…
-
What changed in 2026, by region Replied, post #114 · Access › International · 1 Feb 2025 · 1 like Worth separating two things that post #111 runs together. Temperature-controlled material and long-haul travel is a practical problem with practical solutions, none of…
-
A page that has drifted out of date and needs a maintainer Replied, post #57 · Documentation › Wiki requests · 28 Jan 2025 · 1 like Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
Isotonicity and what happens when you get it wrong Replied, post #31 · Pharmacology › Formulation chemistry · 17 Jan 2025 · 23 likes Worth separating two things that post #29 runs together. Isotonicity is a good example of a question where the honest answer is boring and the interesting answers are…
-
Coming back to: When to suspect the method rather than the sample Replied, post #113 · Analytics › Method validation · 22 Dec 2024 · 5 likes Reporting a result to more decimal places than the method's precision supports is a small dishonesty that appears everywhere. A method with a two per cent relative…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #6 · Pharmacology › Receptor biology · 16 Dec 2024 · 0 likes Post #3 is right about the mechanism and I think understates the practical bit. Reporting rather than recommending, on Biased agonism. What happened is above. Whether…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #70 · Access › Insurance & coverage · 15 Dec 2024 · 0 likes Adding the measurement that post #69 says would settle it. On Step therapy requirements the community has more anecdote than the confidence in this thread implies, and…
-
Coming back to: When to suspect the method rather than the sample Replied, post #39 · Analytics › Method validation · 7 Dec 2024 · 18 likes Documented validation is what separates a number from an opinion expressed numerically. That is the whole reason to ask for the procedure identifier rather than the…
-
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Started this topic · Clinical › Comorbidities · 30 Nov 2024 · 3 likes On the subject in the title: Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Working notes rather than a conclusion. Working notes on…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #22 · Practice › Side effects · 24 Nov 2024 · 1 like The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #40 · Compounds › Semaglutide · 23 Nov 2024 · 0 likes Gallbladder events appear in the labelling for this class and are more common with larger, faster weight reduction. The mechanism is not specific to the drug — rapid…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #5 · Evidence › Journal club · 21 Oct 2024 · 1 like The arithmetic on SURMOUNT-1 is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
Gallbladder disease risk with rapid weight loss Replied, post #21 · Clinical › Comorbidities · 19 Oct 2024 · 17 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Food noise reducing and the disorientation that can follow Replied, post #23 · Wellbeing › Mental health · 16 Oct 2024 · 31 likes Where a member is finding this hard, the useful reply is usually a question rather than an answer, and this subcategory does that well.
-
When "no data" is the complete and final answer Replied, post #4 · marked as the solution · Compounds › Other compounds · 15 Oct 2024 · 8 likes The opening post put the caveat in the right place and I want to underline it. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
-
A page that has drifted out of date and needs a maintainer Replied, post #13 · Documentation › Wiki requests · 27 Sep 2024 · 0 likes Good question, well framed, and I would like to see it answered properly.
-
Correlation in a self-tracked dataset: what it can support Replied, post #108 · Research Methods › Statistics · 24 Aug 2024 · 12 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
-
Blind submission and why it changes minds Replied, post #39 · Sourcing › Independent verification · 18 Aug 2024 · 12 likes Building on post #38 rather than restating it. Small correction to my own earlier position on blind submission. I had the units the wrong way round, which changes the…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #26 · Analytics › COA interpretation · 12 Aug 2024 · 24 likes Fair, and the limits you put on it are the part I will remember.
-
Guidelines revision: what changed and why Replied, post #100 · Meta › Announcements · 28 Jul 2024 · 6 likes Post #96 put the caveat in the right place and I want to underline it. Guidelines revision is one of those subjects where the general answer and the answer for a…
-
Cold packs, phase-change material, and what survives ten days Replied, post #139 · Sourcing › Logistics · 24 Jul 2024 · 12 likes Cold packs is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.